Get the most recent information about COVID-19 from Tufts Health Plan or for more information visit the CDC website.
On December 17, 2019, Glenmark Pharmaceutical Inc., manufacturer of ranitidine, issued a voluntary recall of ranitidine tablets. This recall was issued because an unexpected impurity was found in these products that may cause health risks.
For more information or to report any adverse events or quality problems experienced with the use of this product directly to Glenmark Drug Safety or to the FDA's MedWatch Program.
Manufacturers:
To report an adverse event to the FDA Med Watch Program: